Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Parnassus Core Equity Fund - Investor Shares (PRBLX)

38.90
Net Asset Value
+0.41%
1 Day
-4.40%
Year-to-Date
Overall Morningstar Rating
Large blend
Style or Category
No Load
Sales Expenses
0.87%
Expense Ratio
Low
Morningstar Risk Rating™
Investment Objective The investment seeks to achieve both capital appreciation and current income. The fund's objective is to achieve both capital appreciation and current income by investing primarily in a diversified portfolio of equity securities. Equity securities include common and preferred stock. Under normal circumstances, the fund will invest a minimum of 80% of its net assets (plus borrowings for investment purposes) in equity securities. At least 75% of the fund's total assets will normally be invested in equity securities that pay interest or dividends.

Performance

1 month-5.08% 3 years+15.11%
3 months-4.55% 5 years+14.51%
1 year+0.69% Since inception+10.53%
Data through --

Peer Comparisonvs. Large blend

 PRBLXCategory
Performance 5-yr return+14.51%+15.84%
Expense ratio0.87%1.09%
Risk 5 year sharpe ratio1.421.13
Net assets$11.5B$3.6B
Average market cap$34.8B$94.6B
Average P/E20.518.7
Portfolio turnover14%14%

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyParnassus
Fund manager & tenureTodd Ahlsten / 14 Years
Minimal initial investment$2,000.00
Minimum IRA investment$500.00

Holdings

U.S. stock86.51%
International stock9.99%
Cash3.51%
Fixed income0.00%
Other0.00%
Top 5 Sectors
Portfolio weighting
Financial service 18.54%
Industrial materials 16.59%
Telecommunication 11.46%
Healthcare 10.52%
Energy 10.21%
Top 10 Holdings
Portfolio weighting
DHR Danaher Corp4.66%
MSI Motorola4.50%
MDLZ Mondelez International Inc4.03%
GILD Gilead Sciences3.29%
PNR Pentair plc3.29%
UPS UPS3.25%
AGN Allergan3.22%
CVS CVS Caremark3.19%
PG Procter & Gamble2.93%
SCHW Charles Schwab2.90%

Partner Offers